The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy

Richard E Kast,1 Nicolas Skuli,2 Samuel Cos,3 Georg Karpel-Massler,4 Yusuke Shiozawa,5 Ran Goshen,6 Marc-Eric Halatsch4 1IIAIGC Study Center, Burlington, VT, USA; 2INSERM, Centre de Recherches en Cancérologie de Toulouse – CRCT, UMR1037 Inserm/Université Toulouse III...

Full description

Saved in:
Bibliographic Details
Main Authors: Kast RE, Skuli N, Cos S, Karpel-Massler G, Shiozawa Y, Goshen R, Halatsch ME
Format: article
Language:EN
Published: Dove Medical Press 2017
Subjects:
Online Access:https://doaj.org/article/4e6e679f64db42edab80fb791718a624
Tags: Add Tag
No Tags, Be the first to tag this record!